Remove company astrazeneca
article thumbnail

Digital stethoscope and cardio health algorithm startup Eko pulls in $65M Series C

Mobi Health News

The Oakland, California, company recently announced collaborations with AstraZeneca and 3M Littmann Stethoscopes.

323
323
article thumbnail

Renalytix AI and AstraZeneca team up to improve chronic kidney disease outcomes

Mobi Health News

Artificial intelligence-enabled in vitro diagnostics company Renalytix AI announced today a research partnership with AstraZeneca to develop and launch medical strategies for cardiovascular, renal and metabolic diseases.

256
256
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Major Milestone Met in AI-Powered Fight Against Lung Cancer

Digital Health Global

It saw AstraZeneca , a global biopharmaceutical company, join the WEF EDISON Alliance , a partnership between commercial and non-profit sectors, to improve the lives of people through digital inclusion. Nipun Jain, Head of International A.Catalyst Network at AstraZeneca, states, “ Our partnership with Qure.ai About Qure.ai

article thumbnail

AstraZeneca working with Mass General on tech for heart failure, asthma

Healthcare IT News - Telehealth

The biotechnology company AstraZeneca announced on Tuesday that it would be collaborating with Massachusetts General Hospital to create and clinically validate patient-centric digital health solutions. WHY IT MATTERS. Slavin, president of Massachusetts General Hospital. THE LARGER TREND.

EHR 123
article thumbnail

Patients Look Beyond the Pandemic to Pharma for Engagement, Innovation, and Integrity

Health Populi

Compared with a year ago, more patients and their advocates are seeking quality therapies, innovation, engagement, and integrity from pharmaceutical companies, based on research published today from PatientView. Patient centricity, and, Integrity, plus. Generics such as Mylan and Teva, among others. Roche/Genentech. Gilead Science, and.

BioTech 389
article thumbnail

uMotif gets $3.2M for patient-first approach to clinical trial innovation

Mobi Health News

Patient-facing clinical trial software company uMotif has raised $3.2 Patient-facing clinical trial software company uMotif has raised $3.2 The UK-based company, founded in 2012, works with pharma companies including AstraZeneca, Novartis, UCB, and Merck. million (£2.4 million (£2.4

113
113
article thumbnail

Market access veteran Ellen Cappellino joins Klick Health

Digital Health Global

Over the years, Cappellino spent more than a decade client-side, working at AstraZeneca as Senior Director, Oncology Access Strategy, at Vertex Pharmaceuticals as Senior Director, Managed Markets Marketing, and at Pfizer as Marketing Director. Klick has consistently been named a Best Managed Company and Great Place to Work.